NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
View Top Employees from NewLimitWebsite | https://newlimit.com |
Employees | 27 (18 on RocketReach) |
Founded | 2022 |
Industry | Biotechnology Research |
Looking for a particular NewLimit employee's phone or email?
Gregory Johnson is the Co-founder and Head of Machine Learning of NewLimit.
18 people are employed at NewLimit.
NewLimit is based in South San Francisco, California.